Eldorado Gold (NYSE:EGO – Get Free Report) (TSE:ELD) had its price target decreased by equities research analysts at TD Securities from $20.00 to $19.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “hold” rating on the basic materials company’s stock. TD Securities’ target price suggests a potential upside of 13.91% from the stock’s current price.
A number of other equities analysts have also weighed in on EGO. Scotiabank upped their target price on Eldorado Gold from $18.00 to $20.00 and gave the stock a “sector perform” rating in a research report on Monday, August 19th. CIBC upped their price objective on Eldorado Gold from $18.00 to $22.50 and gave the company an “outperformer” rating in a research note on Wednesday, July 10th. Finally, Royal Bank of Canada upped their price target on Eldorado Gold from $20.00 to $22.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $20.88.
Read Our Latest Stock Report on Eldorado Gold
Eldorado Gold Trading Up 2.1 %
Eldorado Gold (NYSE:EGO – Get Free Report) (TSE:ELD) last issued its earnings results on Thursday, October 31st. The basic materials company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.02. Eldorado Gold had a return on equity of 6.75% and a net margin of 23.16%. The company had revenue of $331.76 million for the quarter. During the same period in the previous year, the company earned $0.17 earnings per share. Analysts anticipate that Eldorado Gold will post 1.45 EPS for the current year.
Institutional Trading of Eldorado Gold
A number of institutional investors have recently added to or reduced their stakes in the stock. Tobam lifted its holdings in Eldorado Gold by 14.8% during the 2nd quarter. Tobam now owns 5,036 shares of the basic materials company’s stock worth $74,000 after purchasing an additional 651 shares in the last quarter. Blue Trust Inc. lifted its holdings in Eldorado Gold by 232.8% during the 3rd quarter. Blue Trust Inc. now owns 1,910 shares of the basic materials company’s stock worth $33,000 after purchasing an additional 1,336 shares in the last quarter. Financial Management Professionals Inc. purchased a new stake in Eldorado Gold during the 3rd quarter worth about $32,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Eldorado Gold by 4.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 45,980 shares of the basic materials company’s stock worth $679,000 after purchasing an additional 1,858 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in Eldorado Gold by 1.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 169,435 shares of the basic materials company’s stock worth $2,499,000 after purchasing an additional 2,472 shares in the last quarter. Hedge funds and other institutional investors own 69.58% of the company’s stock.
Eldorado Gold Company Profile
Eldorado Gold Corporation, together with its subsidiaries, engages in the mining, exploration, development, and sale of mineral products primarily in Turkey, Canada, Greece, and Romania. The company primarily produces gold, as well as silver, lead, and zinc. It holds a 100% interest in the Kisladag and Efemçukuru mines located in Turkey; Lamaque complex located in Canada; and Olympias, Stratoni, Skouries, Perama Hill, and Sapes gold mines located in Greece, as well as the 80.5% interest in Certej development projects located in Romania.
Featured Stories
- Five stocks we like better than Eldorado Gold
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Intel: Is Now the Time to Be Brave?
- How Technical Indicators Can Help You Find Oversold Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What does consumer price index measure?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Eldorado Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eldorado Gold and related companies with MarketBeat.com's FREE daily email newsletter.